[1]
“Compaction and Tableting Behavior of a Novel Co-Processed Excipient in the Formulation of Metoprolol Succinate Tablets”, NJPR, vol. 16, no. 2, pp. 127–142, Dec. 2020, doi: 10.4314/njpr.v16i2.4.